ACQUISITIONS

9 Months Ended

Dec. 31, 2014

ACQUISITIONS [Abstract]

ACQUISITIONS

NOTE 3.  ACQUISITIONS

In November 2014, Abaxis, through its wholly-owned subsidiary, entered into Share Purchase Agreements pursuant to which, Abaxis acquired 100% of the outstanding stock of Quality Clinical Reagents Limited (“QCR”) and Trio Diagnostics (Ireland) Ltd (“Trio”), both based in the United Kingdom.  QCR and Trio are distributors of laboratory instrumentation and consumables to the veterinary profession in the United Kingdom.  Our primary reason for the acquisitions was to continue servicing and supplying Abaxis veterinary products to our customer base.  The acquisition date fair value of the purchase consideration was $6.5 million, which included the following (in thousands):

Cash	$	3,196
Installment payment obligations		2,336
Settlement of preexisting business relationship at fair value		931
Total	$	6,463

As of December 31, 2014, $2.3 million will be payable in two installments during fiscal years 2016 through 2017.  The first installment obligation of GBP 750,000 is payable in fiscal year 2016 and the second installment of GBP 750,000 will be placed in escrow as security for post-closing indemnification obligations of certain of the sellers.  Any amounts remaining in escrow after three years following the closing date will be released to these sellers in fiscal year 2017, net of any outstanding indemnification claims.  The Share Purchase Agreements contain certain customary representations and warranties.  Additionally, in connection with the acquisition, we recorded a settlement of the preexisting business relationship related to accounts receivable due from QCR and Trio that existed on the acquisition date.  The book value of the accounts receivable approximates their fair value due to their short-term nature and no gain or loss was recorded.

The following table summarizes the acquisition date fair value of net tangible assets acquired and liabilities assumed from QCR and Trio (in thousands):

	Fair Value
Net tangible assets acquired	$	5,145
Intangible assets
Customer relationships		1,535
Tradename		16
Deferred tax liabilities		(336	)
Goodwill		103
Total	$	6,463

The useful lives for the customer relationships and tradename intangible assets acquired in the acquisition are ten years and two years, respectively, and will be amortized on a straight-line basis.